Search results for " Lower"

showing 10 items of 378 documents

Les anotacions marginals al «De amore» català

2007

A new, philological edition of the marginal notes in Andreas Capellanus’ «DeAmore’s» medieval Catalan translation, uniquely preserved in Real Biblioteca de Madrid’s manuscript II-3096 (I), accompanied by transcriptions of the sentence or paragraph which each note refers to. These notes are thematically classified in four groups and described so as to outline their medieval annotator’s main interests.

lcsh:Language and LiteratureUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASLingüísticaFilologíasHistory of ideasMedieval Catalan literatureLower Middle Ageslcsh:Philology. Linguisticslcsh:P1-1091History of culturethe Medieval idea of human love:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]History of educationlcsh:PMedieval Catalan literature; History of culture; Lower Middle Ages; History of ideas; the Medieval idea of human love; History of education; erotodidactismerotodidactism
researchProduct

Search for pair production of first or second generation leptoquarks in proton-proton collisions at sqrt(s)=7 TeV using the ATLAS detector at the LHC

2011

This paper describes searches for the pair production of first or second generation scalar leptoquarks using 35  pb−1 of proton-proton collision data recorded by the ATLAS detector at √s=7  TeV. Leptoquarks are searched in events with two oppositely-charged muons or electrons and at least two jets, and in events with one muon or electron, missing transverse momentum and at least two jets. After event selection, the observed yields are consistent with the predicted backgrounds. Leptoquark production is excluded at the 95% CL for masses MLQ<376 (319) GeV and MLQ<422 (362) GeV for first and second generation scalar leptoquarks, respectively, when assuming the branching fraction of a leptoquark…

leptoquark: scalar ; leptoquark: branching ratio ; leptoquark: pair production ; transverse momentum: missing-energy ; ATLAS ; CERN LHC Coll ; p p: interaction ; leptoquark: search for ; final state: ((n)jet dilepton) ; final state: ((n)jet lepton) ; background ; leptoquark: mass: lower limit ; channel cross section: upper limit ; experimental results ; 7000 GeV-cmsHeraSu(15) Grand UnificationScience & Technology:Ciências Físicas [Ciências Naturais]Settore FIS/01 - Fisica SperimentaleHigh Energy Physics::PhenomenologyQuarksFísicaddc:500.2Breaking530pair production; leptoquarks;High Energy Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareConstraintsddc:530High Energy Physics::ExperimentFísica nuclearBosonsParticle Physics - ExperimentDetectors de radiacióModel
researchProduct

Existence and classification of critical points for nondifferentiable functions

2004

A general min-max principle established by Ghoussoub is extended to the case of functionals which are the sum of a locally Lipschitz continuous term and of a convex, proper, lower semicontinuous function. Some topological properties of the min-max-generated critical points in such a framework are then pointed out.

locally Lipschitz continus functionlower semicontinuous functionApplied Mathematicsconvexcritical pointAnalysipropercritical point; locally Lipschitz continus function; convex proper lower semicontinuous function49J3558E05Analysis47J30
researchProduct

Expectation Damages and Bilateral Cooperative Investments

2012

We examine the efficiency of the standard breach remedy expectation damages in a setting where the buyer invests cooperatively and the seller invests both cooperatively and selfishly. Contracts may specify a required quality level and an upper bound to the seller's coordination costs. We find that it is optimal to write an augmented Cadillac contract in which quality is stipulated such that it cannot be met with positive probability together with a very low price. Thus, the seller becomes a residual claimant and the coordination-cost threshold can be used to balance the incentives of the buyer.

media_common.quotation_subjectjel:D86Upper and lower boundsMicroeconomicsEconomicsddc:330C70Production (economics)Incomplete contractsQuality (business)Residual claimantPositive probabilitymedia_commonjel:C70Actuarial scienceK12TheoryofComputation_GENERALInvestment (macroeconomics)jel:K12IncentiveBalance (accounting)ComputingMilieux_COMPUTERSANDSOCIETYQuality levelBusinessExpectation damagesD86LawFinanceAmerican Law and Economics Review
researchProduct

276 Evaluation of cardiovascular risk and factors associated to risk under-evaluation in general practice

2011

Correlation between perceived cardiovascular risk (CVR) by physicians and real CVR is poorly known. Moreover, the underlying question of factors associated to risk misevaluation, especially for patients at high CVR and that could benefit of a lipid lowering therapy (LLT), remains unsolved. Objective and methodology This was an on-line non-interventional study conducted on a sample of 619 general practitioners. The aim was to describe the relation between physicians evaluated CVR and calculated CVR according to risk's scales. All consulting patients’ aged50 years old (YO) were included. Physicians had to complete a questionnaire and to assess patient's CVR on a 3 level scale (low, medium, an…

medicine.medical_specialtyFramingham Risk Scorebusiness.industryDiseasemedicine.diseaseIncreased riskBlood pressureDiabetes mellitusInternal medicineGeneral practiceMedicineLipid loweringPopulation RiskCardiology and Cardiovascular MedicinebusinessArchives of Cardiovascular Diseases Supplements
researchProduct

Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?

2019

Abstract Background Although lipid-lowering drugs, especially statins, and recently also PCSK9 inhibitors can reduce LDL cholesterol (LDL-C) and decrease the risk for cardiovascular disease (CVD) including coronary artery disease (CAD) events most efficiently, only 5–10% of high-risk cardiovascular patients reach the target values recommended by international guidelines. In patients who cannot be treated adequately by drugs it is possible to reduce increased LDL-C and/or lipoprotein(a) (Lp(a)) values by the use of lipoprotein apheresis (LA) with the potential to decrease severe CVD events in the range of 70%->80%. Even in Germany, a country with well-established reimbursement guidelines for…

medicine.medical_specialtyHyperlipoproteinemiasReferralPopulationDisease030204 cardiovascular system & hematologyRisk AssessmentHealth Services AccessibilityCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal MedicinemedicineHumans030212 general & internal medicineIntensive care medicineeducationCompetence (human resources)Reimbursementeducation.field_of_studybusiness.industryPatient SelectionGeneral MedicineCholesterol LDLmedicine.diseaseCardiovascular DiseasesBlood Component RemovalPatient ComplianceLipid loweringCardiology and Cardiovascular MedicinebusinessLipoprotein apheresisBiomarkersLipoprotein(a)Atherosclerosis. Supplements
researchProduct

Issues in the development of new combinations of blood pressure lowering drugs

2010

medicine.medical_specialtyPharmacotherapyBlood pressurePhysiologybusiness.industryAnesthesiaInternal MedicinemedicineBlood pressure loweringCardiology and Cardiovascular MedicinebusinessSurgeryJournal of Hypertension
researchProduct

Efficacy and acceptance of the sacral neuromodulation in the treatment of female lower urinary tract dysfunctions.

2017

medicine.medical_specialtySacrum030232 urology & nephrologyUrologyMEDLINEElectric Stimulation Therapylower urinary tract dysfunctionsacral neuromodulationFemale lower urinary tract03 medical and health sciences0302 clinical medicineMedicineHumansElectric stimulation therapyProspective StudiesProspective cohort study030219 obstetrics & reproductive medicineUrinary bladderbusiness.industryUrinary retentionUrinary Bladder OveractiveObstetrics and GynecologyMiddle AgedPatient Acceptance of Health CareUrinary RetentionSacrummedicine.anatomical_structureTreatment OutcomeSacral nerve stimulationFemalemedicine.symptombusinessMinerva ginecologica
researchProduct

Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk

2014

Statins are the first-line therapy in LDL-Cholesterol (LDL-C) reduction and its clinical use has contributed to significant prevention and treatment of atherosclerotic vascular disease. Yet, a significant proportion of patients remain at high risk. Recently, a number of new therapies have been developed to further lower LDL-C. These agents may provide clinical benefit on top of statin therapy in patients with high residual risk, severe hypercholesterolemia or as an alternative for patients who are intolerant to statins. We review four novel approaches based on the inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein-B100 (apoB), Cholesteryl ester transport pro…

medicine.medical_specialtySettore MED/09 - Medicina InternaApolipoprotein BHypercholesterolemiaMipomersenFamilial hypercholesterolemiaBioinformaticschemistry.chemical_compoundRisk FactorsAnacetrapibInternal medicinemedicineHumansStatins Novel LDL-C lowering drugs Mipomersen Lomitapide Anacetrapib Evacetrapib PCSK9 inhibitorsbiologybusiness.industryAnticholesteremic AgentsPCSK9nutritional and metabolic diseasesLipid Metabolismmedicine.diseaseLomitapideResidual riskEndocrinologychemistryCardiovascular Diseasesbiology.proteinlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessEvacetrapibCurrent Atherosclerosis Reports
researchProduct

Do we understand the pathophysiology of GERD after sleeve gastrectomy?

2020

Gastroesophageal reflux disease (GERD), a prevalent problem among obese individuals, is strongly associated with obesity and weight loss. Hence, bariatric surgery effectively improves GERD for many patients. Depending on the type of bariatric procedure, however, surgery can also worsen or even cause a new onset of GERD. As a consequence, GERD remains a relevant problem for many bariatric patients, and especially those who have undergone sleeve gastrectomy (SG). Affected patients report not only a decrease in physical functioning but also suffer from mental and emotional problems, resulting in poorer social functioning. The pathomechanism of GERD after SG is most likely multifactorial and tr…

medicine.medical_specialtySleeve gastrectomymedicine.medical_treatmentBariatric Surgery030209 endocrinology & metabolismDiseaseGeneral Biochemistry Genetics and Molecular BiologyEsophageal Sphincter LowerHiatal hernia03 medical and health sciences0302 clinical medicinePostoperative ComplicationsHistory and Philosophy of ScienceWeight lossGastrectomyWeight LossMedicineHumansObesityIntensive care medicinebusiness.industryGeneral Neurosciencemedicine.diseaseObesityhumanitiesdigestive system diseasesPathophysiologyHernia HiatalTreatment OutcomeGERDGastroesophageal Reflux030211 gastroenterology & hepatologyGastrectomymedicine.symptombusinessAnnals of the New York Academy of SciencesReferences
researchProduct